Steven Cohen’s Core Laboratories CLB Stock Holding History

Steven Cohen’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-71,735	Closed	-$887K	–	3933
2025 Q3	$887K	Buy	71,735 +9,435	+15%	+$111K	﹤0.01%	1740
2025 Q2	$718K	Buy	+62,300	New	+$739K	﹤0.01%	1671
2025 Q1	–	Sell	-15,344	Closed	-$266K	–	2100
2024 Q4	$266K	Buy	+15,344	New	+$296K	﹤0.01%	1821
2019 Q3	–	Sell	-4,615	Closed	-$241K	–	1171
2019 Q2	$241K	Buy	+4,615	New	+$271K	﹤0.01%	943
2016 Q2	–	Sell	-5,000	Closed	-$562K	–	736
2016 Q1	$562K	Buy	+5,000	New	+$519K	﹤0.01%	654
2015 Q4	–	Sell	-11,932	Closed	-$1.19M	–	696
2015 Q3	$1.19M	Buy	+11,932	New	+$1.3M	0.01%	608

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Steven Cohen's CLB Position: Q4 2025 in Review

Steven Cohen sold out of Core Laboratories (CLB) in Q4 2025, closing a stake of 71,735 shares — an estimated $887K sold.

Steven Cohen first reported a position in CLB in Q3 2015 and held it in 6 quarters. The position peaked at $1.19M in Q3 2015. 187 funds tracked by Wall St. Rank hold CLB as of Q4 2025.

Steven Cohen reported no remaining Core Laboratories position as of Q4 2025 after selling out during the quarter.
Steven Cohen sold 71,735 Core Laboratories shares in Q4 2025, an estimated $887K.
Steven Cohen first reported a position in Core Laboratories in Q3 2015 and held it in 6 quarters.
Steven Cohen's Core Laboratories position peaked at $1.19M in Q3 2015.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.